» Articles » PMID: 36352465

Dysregulation of Neuroprotective Astrocytes, a Spectrum of Microglial Activation States, and Altered Hippocampal Neurogenesis Are Revealed by Single-cell RNA Sequencing in Prion Disease

Overview
Publisher Biomed Central
Specialty Neurology
Date 2022 Nov 10
PMID 36352465
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases are neurodegenerative disorders with long asymptomatic incubation periods, followed by a rapid progression of cognitive and functional decline culminating in death. The complexity of intercellular interactions in the brain is challenging to unravel and the basis of disease pathobiology remains poorly understood. In this study, we employed single cell RNA sequencing (scRNAseq) to produce an atlas of 147,536 single cell transcriptomes from cortex and hippocampus of mice infected with prions and showing clinical signs. We identified transcriptionally distinct populations and sub-populations of all the major brain cell-types. Disease-related transcription was highly specific to not only overarching cell-types, but also to sub-populations of glia and neurons. Most striking was an apparent decrease in relative frequency of astrocytes expressing genes that are required for brain homeostasis such as lipid synthesis, glutamate clearance, synaptic modulation and regulation of blood flow. Additionally, we described a spectrum of microglial activation states that suggest delineation of phagocytic and neuroinflammatory functions in different cell subsets. Differential responses of immature and mature neuron populations were also observed, alongside abnormal hippocampal neurogenesis. Our scRNAseq library provides a new layer of knowledge on single cell gene expression in prion disease, and is a basis for a more detailed understanding of cellular interplay that leads to neurodegeneration.

Citing Articles

Excitatory neuron-prone prion propagation and excitatory neuronal loss in prion-infected mice.

Erdenebat T, Komatsu Y, Uwamori N, Tanaka M, Hoshika T, Yamasaki T Front Mol Neurosci. 2024; 17:1498142.

PMID: 39726739 PMC: 11669680. DOI: 10.3389/fnmol.2024.1498142.


Single-cell transcriptomics unveils molecular signatures of neuronal vulnerability in a mouse model of prion disease that overlap with Alzheimer's disease.

Slota J, Lamoureux L, Frost K, Sajesh B, Booth S Nat Commun. 2024; 15(1):10174.

PMID: 39580485 PMC: 11585576. DOI: 10.1038/s41467-024-54579-2.


NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling.

Liu Y, Guo J, Matoga M, Korotkova M, Jakobsson P, Aguzzi A Nat Neurosci. 2024; 27(8):1534-1544.

PMID: 38802591 PMC: 11303249. DOI: 10.1038/s41593-024-01663-x.


The Role of Glial Cells in Neurobiology and Prion Neuropathology.

Hay A, Popichak K, Moreno J, Zabel M Cells. 2024; 13(10.

PMID: 38786054 PMC: 11119027. DOI: 10.3390/cells13100832.


Selective Vulnerability to Neurodegenerative Disease: Insights from Cell Type-Specific Translatome Studies.

Jackson W, Bauer S, Kaczmarczyk L, Magadi S Biology (Basel). 2024; 13(2).

PMID: 38392286 PMC: 10886597. DOI: 10.3390/biology13020067.


References
1.
Phatnani H, Maniatis T . Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol. 2015; 7(6). PMC: 4448607. DOI: 10.1101/cshperspect.a020628. View

2.
Nikolakopoulou A, Dutta R, Chen Z, Miller R, Trapp B . Activated microglia enhance neurogenesis via trypsinogen secretion. Proc Natl Acad Sci U S A. 2013; 110(21):8714-9. PMC: 3666689. DOI: 10.1073/pnas.1218856110. View

3.
Steele A, Emsley J, Ozdinler P, Lindquist S, Macklis J . Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci U S A. 2006; 103(9):3416-21. PMC: 1413927. DOI: 10.1073/pnas.0511290103. View

4.
Daneman R, Prat A . The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015; 7(1):a020412. PMC: 4292164. DOI: 10.1101/cshperspect.a020412. View

5.
Tognatta R, Miller R . Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies. Neuropharmacology. 2016; 110(Pt B):539-547. PMC: 5512544. DOI: 10.1016/j.neuropharm.2016.04.026. View